Conflict of Interest Disclosures: Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Martinez reported having received support from Forest, Janssen, GlaxoSmithKline, Nycomed/Takeda, Amgen, Astra Zeneca, Boehringer Ingelheim, Carden Jennings, CSA Medical, Ikaria/Bellerophon, Genentech, Merck, Novartis, Pearl, Pfizer, Roche, Sunovion, Theravance, Axon, CME Incite, the California Society for Allergy and Immunology, Annenberg, Inova Health System, Integritas, InThought, Miller Medical, the National Association for Continuing Education, Paradigm, Peer Voice, UpToDate, Haymarket Communications, St John’s Hospital, St Mary’s Hospital, the Western Society of Allergy and Immunology, Informa, Bioscale, Unity Biotechnology, Centocor, Gilead, Promedior, Ikaria, Kadmon, Vertex, Veracyte, the American Thoracic Society, Academic CME, Falco, MedScape, the National Association for Continuing Education, Axon Communication, Genzyme, Johnson & Johnson, Spectrum Health System, University of Texas Southwestern, and Biogen and having received grants from the National Institutes of Health and National Heart, Lung, and Blood Institute. Dr O’Connor reported receiving research funding from the National Heart, Lung, and Blood Institute via a subcontract from Dimagi, Inc, in which he has no financial interest.
Funding/Support: Funding for this editorial in part comes from the National Institutes of Health via grant 1R01 HL1144055 (Dr Martinez) and contract HHSN268201200010C (Dr O’Connor).
Role of the Funder/Sponsor: The National Institutes of Health had no role in the preparation, review, or approval of the manuscript.